Precipio Launches ICE COLD-PCR(TM) Research Access Program for Cancer Centers
COMPLIMENTARY PRECIPIO ICE COLD PCR™ KITS NOW AVAILABLE TO ADVANCE BODY OF RESEARCH AND ACCELERATE MARKET EXPANSION NEW HAVEN, Conn., April 11, 2018 (GLOBE NEWSWIRE) — Specialty diagnostics company Precipio, Inc. (NASDAQ:PRPO), announced today the launch of its program to provide complimentary ICE COLD-PCR (ICP) kits to cancer researchers studying the field of liquid biopsy. The program... Read more